Airway angiopoietin-2 in ventilated very preterm infants: association with prenatal factors and neonatal outcome

Pediatr Pulmonol. 2011 Aug;46(8):777-84. doi: 10.1002/ppul.21435. Epub 2011 Feb 18.

Abstract

Objective: Pulmonary angiogenesis is a prerequisite for lung development. Angiopoietin-2 (Ang2) destabilizes endothelial cells through its endothelial receptor TIE-2, enabling vascular sprouting. Ang1 stabilizes new blood vessels. Soluble TIE-2 (sTIE-2) modulates these effects. We hypothesized that histological funisitis is associated with alterations of Ang2 in airways and of the systemic angiopoietin-TIE-2 homeostasis in very low birth weight (VLBW) infants, contributing to pulmonary morbidity and mortality.

Methods: We measured Ang2 in tracheobronchial aspirate fluid (TAF) of 42 VLBW <30 weeks of gestation from day 1 through 15 and Ang1, Ang2, and sTIE-2 in umbilical cord serum of 28 infants by enzyme-linked immunosorbent assay. Histological examination distinguished three groups: funisitis, chorioamnionitis, and controls.

Results: Funisitis was associated with lower Ang2 values in TAF but not with changes of Ang1, Ang2, and sTIE-2 in umbilical cord serum. Infants who developed bronchopulmonary dysplasia (BPD) or died had a persistently decreased ratio of previously measured Ang1 to Ang2 in TAF on days 1-5 and increased cord serum concentrations of sTIE-2. Moderate BPD/death was associated with an increase of Ang2 in TAF on day 10 and decreased Ang1/Ang2 ratio from day 3-15. Small for gestational age (SGA) infants had increased Ang2 in TAF on day 1-7 and a lower Ang1/Ang2 ratio on days 5-7.

Conclusions: The predominance of Ang2 in airway fluid of infants with BPD/death and SGA infants suggests a link between disrupted placental and fetal pulmonary angiogenesis. Histological funisitis with reduced Ang2 in TAF was of minor relevance for outcome in our cohort.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiopoietin-1 / blood
  • Angiopoietin-2 / analysis
  • Angiopoietin-2 / blood
  • Angiopoietin-2 / metabolism*
  • Bronchoalveolar Lavage Fluid / chemistry
  • Bronchopulmonary Dysplasia / blood
  • Bronchopulmonary Dysplasia / metabolism
  • Bronchopulmonary Dysplasia / mortality
  • Chorioamnionitis / metabolism
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / metabolism
  • Infant, Newborn, Diseases / mortality
  • Infant, Very Low Birth Weight*
  • Male
  • Pregnancy
  • Pregnancy Complications / metabolism
  • Pregnancy Complications / mortality
  • Premature Birth / metabolism*
  • Treatment Outcome

Substances

  • Angiopoietin-1
  • Angiopoietin-2